Do early HER2-overexpression breast cancer patients benefit from undergoing neoadjuvant trastuzumab and mastectomy? A meta-analysis

Overview of attention for article published in Cancer Management and Research, August 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

video: 1 YouTube creator

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X YouTube Dimensions citations

So far, Altmetric has seen 1 X post from an account with 789 followers.

Do early HER2-overexpression breast cancer patients benefit from under | CMAR - Dove Medical Press https://t.co/EGFpGGphH2

Reply Repost Favourite